300529.SZShenzhen
Jafron Biomedical Co.,Ltd.
¥15.80
ListedAug 2, 2016
SectorHealthcare
IndustryMedical Devices
CountryChina
Employees2301
State-| CityZhuhai| AddressNo. 98 Technology Six Road| Phone86 75 6368 9708
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
24.6
?
Div. Rate
¥0.52
?
Div. Yield
2.86%
?
Payout Ratio
108.11%
?
Max Consec. Div. Years
9 years
?
Longest Consec. Div.
9 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.27
?
Div. Growth Rate
50.00%
?
Score
82

Dividend History

Historical dividend payments by ex-dividend date.

Jun 1, 2026
¥ 0.5200
May 26, 2025
¥ 0.8000
May 31, 2024
¥ 0.4000
May 31, 2023
¥ 0.6700
Jun 10, 2022
¥ 0.9000
May 12, 2021
¥ 0.6600
May 20, 2020
¥ 0.4737
May 13, 2019
¥ 0.3158
Jun 8, 2018
¥ 0.1842
Jun 13, 2017
¥ 0.1053

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!